| Type | Subsidiary |
| Parent Company | Predictive Oncology |
| HQ | Pittsburgh, PA, US |
| Website | helomics.com |
| Cybersecurity rating | BMore |
Helomics is headquartered in Pittsburgh, PA, US
Viewing summary data as a guest
Sign up for free to see all dataHelomics Office Locations
Helomics has an office in Pittsburgh
Pittsburgh, PA, US (HQ)
91 43rd St #110
Helomics Financials and Metrics
Summary Metrics
Total Funding | $231.5 m |
Investors | Longitude Capital, Birchmere Ventures, Bain Capital, HealthCare Royalty Partners, Adams Capital Management, TVM Capital, Draper Triangle, Quaker BioVentures, Techno Venture Management, Stephens |
In total, Helomics had raised $231.5 m. Helomics is a subsidiary of Predictive Oncology
Helomics Cybersecurity Score
Helomics Online and Social Media Presence
1.65k Twitter followers
Helomics has 1.65k Twitter Followers. The number of followers has increased 0.1% quarter over quarter
Helomics's Trends
Helomics News and Updates
August 03, 2021
Predictive Oncology subsidiary, Helomics uses data from the 100,000 Genomes Project to better predict ovarian cancer outcomes
Initial results demonstrate that AI models of genomic data can predict cancer outcomes. This has the potential to help personalize ovarian cancer treatments and drive the discovery of new therapies. Initial results demonstrate that AI models of genomic data can predict cancer outcomes. This has the …
February 24, 2021
POAI ‘s Helomics Division Announces Progress on Milestones for its AI-Driven Model of Ovarian Cancer
Helomics Researchers Complete Key Sequencing Milestones and Focus on AI-Driven Model Building Helomics Researchers Complete Key Sequencing Milestones and Focus on AI-Driven Model Building
February 08, 2021
Predictive Oncology’s Wholly Owned Subsidiary Helomics announces the start of its drug repurposing project using its ground-breaking PeDAL™ platform for ovarian cancer
MINNEAPOLIS, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced today that it will start an in-house drug repurposing project, focused on ovarian …
August 14, 2020
Predictive Oncology Announces DojoLIVE! Interview with Helomics CIO Mark Collins, ‘Can We Cure Cancer with Artificial Intelligence?’
LOS ANGELES, Aug. 14, 2020 (GLOBE NEWSWIRE) -- via NetworkWire — Predictive Oncology Inc. (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announces that Mark Collins, Ph.D., chief innovation officer of…
Helomics Blogs
June 26, 2019
Predictive Oncology Subsidiary, Helomics, Signs Collaborative Research Agreement with ChemImage to Expand Personalized Medicine to Prostate Cancer Prognosis and Treatment
MINNEAPOLIS, Minn., June 26, 2019 (GLOBE NEWSWIRE) – Predictive Oncology(Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today it has signed a collaborative research agreement with Pi…
Helomics Frequently Asked Questions
How many employees does Helomics have?
Helomics has 80 employees.
Who are Helomics competitors?
Competitors of Helomics include Personalis, MTM and Datos Health.
Where is Helomics headquarters?
Helomics headquarters is located at 91 43rd St #110, Pittsburgh.
Where are Helomics offices?
Helomics has an office in Pittsburgh.
How many offices does Helomics have?
Helomics has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies